Harmine stimulates proliferation of human neural progenitors
- PMID: 27957390
- PMCID: PMC5144684
- DOI: 10.7717/peerj.2727
Harmine stimulates proliferation of human neural progenitors
Abstract
Harmine is the β-carboline alkaloid with the highest concentration in the psychotropic plant decoction Ayahuasca. In rodents, classical antidepressants reverse the symptoms of depression by stimulating neuronal proliferation. It has been shown that Ayahuasca presents antidepressant effects in patients with depressive disorder. In the present study, we investigated the effects of harmine in cell cultures containing human neural progenitor cells (hNPCs, 97% nestin-positive) derived from pluripotent stem cells. After 4 days of treatment, the pool of proliferating hNPCs increased by 71.5%. Harmine has been reported as a potent inhibitor of the dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A), which regulates cell proliferation and brain development. We tested the effect of analogs of harmine, an inhibitor of DYRK1A (INDY), and an irreversible selective inhibitor of monoamine oxidase (MAO) but not DYRK1A (pargyline). INDY but not pargyline induced proliferation of hNPCs similarly to harmine, suggesting that inhibition of DYRK1A is a possible mechanism to explain harmine effects upon the proliferation of hNPCs. Our findings show that harmine enhances proliferation of hNPCs and suggest that inhibition of DYRK1A may explain its effects upon proliferation in vitro and antidepressant effects in vivo.
Keywords: Antidepressant; Ayahuasca; DYRK1A; Proliferation; hNPC.
Conflict of interest statement
The authors declare there are no competing interests.
Figures
Similar articles
-
How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition-The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine.Molecules. 2020 Dec 16;25(24):5962. doi: 10.3390/molecules25245962. Molecules. 2020. PMID: 33339338 Free PMC article.
-
Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.Eur J Pharm Sci. 2021 Jul 1;162:105821. doi: 10.1016/j.ejps.2021.105821. Epub 2021 Mar 27. Eur J Pharm Sci. 2021. PMID: 33781856 Free PMC article.
-
Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.J Neurosci Res. 2012 May;90(5):999-1010. doi: 10.1002/jnr.23007. Epub 2012 Jan 18. J Neurosci Res. 2012. PMID: 22252917
-
Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):263-72. doi: 10.1016/j.pnpbp.2012.06.001. Epub 2012 Jun 9. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22691716 Review.
-
Activation, regulation, and inhibition of DYRK1A.FEBS J. 2011 Jan;278(2):246-56. doi: 10.1111/j.1742-4658.2010.07956.x. Epub 2010 Dec 3. FEBS J. 2011. PMID: 21126318 Review.
Cited by
-
Psychedelic-inspired approaches for treating neurodegenerative disorders.J Neurochem. 2022 Jul;162(1):109-127. doi: 10.1111/jnc.15544. Epub 2021 Dec 5. J Neurochem. 2022. PMID: 34816433 Free PMC article. Review.
-
Exploring the Structural Importance of the C3=C4 Double Bond in Plant Alkaloids Harmine and Harmaline on Their Binding Interactions with Hemoglobin.ACS Omega. 2023 Sep 28;8(40):37054-37064. doi: 10.1021/acsomega.3c04432. eCollection 2023 Oct 10. ACS Omega. 2023. PMID: 37841109 Free PMC article.
-
A Systematic Review on the Therapeutic Effects of Ayahuasca.Plants (Basel). 2023 Jul 7;12(13):2573. doi: 10.3390/plants12132573. Plants (Basel). 2023. PMID: 37447135 Free PMC article. Review.
-
Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy.Front Pharmacol. 2024 Jun 19;15:1418555. doi: 10.3389/fphar.2024.1418555. eCollection 2024. Front Pharmacol. 2024. PMID: 38962319 Free PMC article. Review.
-
Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains.Cell Biosci. 2022 Dec 1;12(1):189. doi: 10.1186/s13578-022-00928-x. Cell Biosci. 2022. PMID: 36451159 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
